An Informal AMBER Small Molecule Force Field:
parm@Frosst
Credit
Christopher Bayly, lead the effort between (1992-2010)
Daniel McKay, contributed between (1997-2010)
Jean-François Truchon, contributed between (2002-2010)
This presents a molecular mechanics force field (FF) extending the AMBER FF
to bioorganic small molecules of pharmaceutical interest. The presented
parm@Frosst FF enables the simulation of biomolecules (enzymes, DNA,
peptides, etc.) in the presence of complex organic molecules such as
inhibitor and cofactors. As such it can be used as a small-molecule
supplement to the AMBER parm9x or ffxx biomolecular force fields, as an
alternative to e.g. gaff. The development took place at Merck Frosst Canada,
a subsidiary of Merck & Co, between 1992 and 2010 in the context of
numerous drug-discovery projects. As a result, parm@Frosst, when used to
extend one of the "standard" AMBER force fields such as ff99sb,
could successfully parameterize approximately 85% of the Merck corporate
collection (of small molecules) in 2009 (personal communication to CIB from
V. Hornak).
Merck & Co generously cleared this material to be released to the
scientific community.
John Irwin and Brian Schoichet generously permitted us to use a fraction of
the ZINC dataset (zinc.docking.org).
This data repository contains enough information to 1) implement the
parm@Frosst force field and validate the implementation 2) validate the atom
and bond typing of an implementation of the AM1BCC charge model as
originally published.
You can also retrieve all the files listed above as a compressed tar (parm_at_Frosst.tgz) or a zip (parm_at_Frosst.zip) archive.
NOTE THAT E-MAIL ADDRESSES HAVE BEEN MODIFIED!!!